1. Sense and nonsense in sensors

   • J. Hermanides
   • J. H. DeVries

   Commentary Open access 10 January 2010 Pages: 593 - 596

2. The rise and fall of the metabolic syndrome

   • K. Borch-Johnsen
   • N. Wareham

   Commentary 19 January 2010 Pages: 597 - 599

3. The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation

   • R. K. Simmons
   • K. G. M. M. Alberti
   • G. Roglic

   For Debate 11 December 2009 Pages: 600 - 605

4. The environment within: how gut microbiota may influence metabolism and body composition

   • A. Vrieze
   • F. Holleman
   • M. Nieuwdorp

   Review Open access 26 January 2010 Pages: 606 - 613

   

5. Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass

   • B. Keymeulen
   • M. Walter
   • D. Pipeleers

   Article 14 January 2010 Pages: 614 - 623

   

6. The effects of aerobic exercise on metabolic risk, insulin sensitivity and intrahepatic lipid in healthy older people from the Hertfordshire Cohort Study: a randomised controlled trial

   • F. M. Finucane
   • S. J. Sharp
   • N. J. Wareham

   Article 06 January 2010 Pages: 624 - 631

   

7. Effects of aerobic exercise, resistance exercise or both, on patient-reported health status and well-being in type 2 diabetes mellitus: a randomised trial

   • R. D. Reid
   • H. E. Tulloch
   • D. Coyle

   Article 13 December 2009 Pages: 632 - 640

   

8. Birthweight and the risk of childhood-onset type 1 diabetes: a meta-analysis of observational studies using individual patient data

   • C. R. Cardwell
   • L. C. Stene
   • C. C. Patterson

   Article 10 January 2010 Pages: 641 - 651

   

9. Glycaemic status influences the nature and severity of coronary artery disease

   • C. Berry
   • S. Noble
   • J.-C. Tardif

   Article 14 January 2010 Pages: 652 - 658

10. Identification of asymptomatic type 2 diabetes mellitus patients with a low, intermediate and high risk of ischaemic heart disease: is there an algorithm?

    • M. K. Poulsen
    • J. E. Henriksen
    • H. Beck-Nielsen

    Article 14 January 2010 Pages: 659 - 667

    

11. Life-course weight characteristics and the risk of gestational diabetes

    • E. H. Yeung
    • F. B. Hu
    • C. Zhang

    Article 31 December 2009 Pages: 668 - 678

    

12. Improvements in glucose homeostasis in response to regular exercise are influenced by the PPARG Pro12Ala variant: results from the HERITAGE Family Study

    • S.-M. Ruchat
    • T. Rankinen
    • L. Pérusse

    Article 31 December 2009 Pages: 679 - 689

13. Dimorphic histopathology of long-standing childhood-onset diabetes

    • R. Gianani
    • M. Campbell-Thompson
    • G. S. Eisenbarth

    Article 09 January 2010 Pages: 690 - 698

    

14. Effect of forkhead box O1 (FOXO1) on beta cell development in the human fetal pancreas

    • M. Al-Masri
    • M. Krishnamurthy
    • R. Wang

    Article 24 December 2009 Pages: 699 - 711

    

15. Evidence for neuroendocrine function of a unique splicing form of TCF7L2 in human brain, islets and gut

    • L. Prokunina-Olsson
    • J. L. Hall

    Short Communication Open access 24 December 2009 Pages: 712 - 716

    

16. Enhancement of glucagon secretion in mouse and human pancreatic alpha cells by protein kinase C (PKC) involves intracellular trafficking of PKCα and PKCδ

    • Y. Z. De Marinis
    • E. Zhang
    • L. Eliasson

    Article 18 December 2009 Pages: 717 - 729

    

17. Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cells

    • I. Hadjiyanni
    • K. A. Siminovitch
    • D. J. Drucker

    Article 08 January 2010 Pages: 730 - 740

    

18. Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in NOD mice

    • A. S. Lee
    • D. L. Gibson
    • J. P. Dutz

    Article 13 December 2009 Pages: 741 - 748

    

19. Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance

    • A. Mari
    • A. Tura
    • The RISC Investigators

    Article 09 January 2010 Pages: 749 - 756

    

20. Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men

    • E. S. Tai
    • M. L. S. Tan
    • C. B. Newgard

    Article 15 January 2010 Pages: 757 - 767

21. Biguanides and thiazolidinediones inhibit stimulated lipolysis in human adipocytes through activation of AMP-activated protein kinase

    • O. Bourron
    • M. Daval
    • F. Foufelle

    Article 31 December 2009 Pages: 768 - 778

    

22. Increased tissue kallikrein levels in type 2 diabetes

    • D. J. Campbell
    • A. Kladis
    • D. J. Kelly

    Article 10 January 2010 Pages: 779 - 785

    

23. Regeneration of insulin production by autologous bone marrow blood autotransplantation in patients with type 1 diabetes

    • E. Esmatjes
    • X. Montaña
    • P. Marin

    Research Letter 26 January 2010 Pages: 786 - 789

24. Insufficient evaluation of adverse events is not a proof of safety

    • L. G. Hemkens
    • U. Grouven
    • P. T. Sawicki

    Letter 23 January 2010 Pages: 790 - 792

25. Insufficient evaluation of adverse events is not a proof of safety. Reply to LG Hemkens, U Grouven, R Bender, et al. [letter]

    • P. D. Home
    • P. Lagarenne

    Letter Open access 19 January 2010 Pages: 793 - 794

26. Is rs34861192 or rs1862513 a more promising variant for determining plasma resistin in an aged Japanese population?

    • H. Osawa
    • Y. Tabara
    • H. Makino

    Letter Open access 04 February 2010 Pages: 795 - 797